Sinopharm Tech Holdings Limited (HKG:8156)
Hong Kong · Delayed Price · Currency is HKD 0.1980
-0.0110 (-5.26%)
Sep 23, 2026, 4:08 PM HKT
Sinopharm Tech Holdings Balance Sheet
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 5.62 | 6.95 | 2.64 | 1.78 | 2.99 |
Cash & Short-Term Investments | 5.62 | 6.95 | 2.64 | 1.78 | 2.99 |
Cash Growth | -19.13% | 163.11% | 48.65% | -40.62% | -60.02% |
Accounts Receivable | 5.72 | 18.13 | 20.03 | 8.1 | 28.42 |
Other Receivables | 6.05 | 8.32 | 8.52 | 14.83 | 14 |
Receivables | 11.76 | 26.44 | 28.56 | 22.93 | 42.42 |
Inventory | 0.12 | 13.48 | 3.54 | 0.86 | 1.35 |
Prepaid Expenses | 3.31 | 2.17 | 3.05 | 0.36 | 0.55 |
Other Current Assets | 0.16 | 0.1 | 0.29 | 1.13 | 0.77 |
Total Current Assets | 20.97 | 49.13 | 38.07 | 27.05 | 48.08 |
Property, Plant & Equipment | 1.47 | 2.6 | 3.88 | 1.16 | 4.65 |
Long-Term Investments | - | - | 2.54 | 5.27 | 23.62 |
Other Long-Term Assets | - | - | - | - | 0.54 |
Total Assets | 22.44 | 51.74 | 44.49 | 33.48 | 76.89 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 9.16 | 22.94 | 32.49 | 34.93 | 54.59 |
Accrued Expenses | 0.89 | 1.12 | 1.27 | 4.5 | 7.61 |
Short-Term Debt | 22.37 | 18.61 | 71.93 | 53 | 8.49 |
Current Portion of Long-Term Debt | 14.8 | 7.4 | - | - | 45 |
Current Portion of Leases | - | 0.67 | 0.67 | - | 0.93 |
Current Income Taxes Payable | 0.17 | 0.16 | 0.12 | 0.03 | 0.03 |
Current Unearned Revenue | 3.54 | 3.15 | 2.63 | 3.8 | 2.79 |
Other Current Liabilities | 4.46 | 14.32 | 140.32 | 116.97 | 129.54 |
Total Current Liabilities | 55.39 | 68.38 | 249.44 | 213.24 | 250.28 |
Long-Term Debt | 15.93 | 20.05 | - | - | - |
Long-Term Leases | - | - | 0.65 | - | - |
Total Liabilities | 71.32 | 88.43 | 250.09 | 213.24 | 250.28 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 7.92 | 7.92 | 57.4 | 57.4 | 56.72 |
Additional Paid-In Capital | 2,742 | 2,742 | 2,704 | 2,704 | 2,702 |
Retained Earnings | -2,947 | -2,938 | -2,993 | -2,974 | -2,988 |
Comprehensive Income & Other | 31.32 | 31.86 | 31.98 | 39.63 | 62.64 |
Total Common Equity | -166.26 | -156.73 | -199.48 | -172.73 | -166.78 |
Minority Interest | -2.48 | 0.17 | -6.12 | -7.02 | -6.62 |
Shareholders' Equity | -48.88 | -36.69 | -205.6 | -179.75 | -173.4 |
Total Liabilities & Equity | 22.44 | 51.74 | 44.49 | 33.48 | 76.89 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 53.1 | 46.73 | 73.26 | 53 | 54.42 |
Net Cash (Debt) | -47.48 | -39.79 | -70.62 | -51.22 | -51.43 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.07 | -0.09 | -0.38 | -0.28 | -0.29 |
Filing Date Shares Outstanding | 633.69 | 633.69 | 183.69 | 183.69 | 181.51 |
Total Common Shares Outstanding | 633.69 | 633.69 | 183.69 | 183.69 | 181.51 |
Working Capital | -34.42 | -19.24 | -211.37 | -186.19 | -202.21 |
Book Value Per Share | -0.26 | -0.25 | -1.09 | -0.94 | -0.92 |
Tangible Book Value | -166.26 | -156.73 | -199.48 | -172.73 | -166.78 |
Tangible Book Value Per Share | -0.26 | -0.25 | -1.09 | -0.94 | -0.92 |
Machinery | 6.55 | 6.41 | 6.36 | 17.8 | 31.69 |
Leasehold Improvements | 0.66 | 0.63 | 0.62 | 6.21 | 6.25 |